Comparison the effects of naproxen, indomethacin and ibuprofen in treatment of spotting due to IUD insertion

Message:
Abstract:
Introduction
IUD is one of the most effective and reversible methods of contraception with the widespread use worldwide. Spotting is the most important side effect of this method that due to discontinuing and removal of IUD. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are effective for treatment of spotting، but in previous study have not identified which one of these drugs is most effective. The aim of this study is to comparison the effects of naproxen، indomethacin and ibuprofen in treatment of spotting due to IUD insertion.
Methods
This semi-experimental study was done in 2010. 943 women randomly allocated to naproxen group (250 mg/q 8 hrs)، indomethacin group (25 mg/q 12 hrs) or ibuprofen group (200 mg/q 6 hrs). Samples are women with IUD Cu T 380 A insertion during a month ago، referring to health centers of Karaj، Iran. All of samples completed 5 days duration of treatment and then they evaluated for spotting. Data analyzed using SPSS16 software with qui-square test، ANOVA and t-test. Significance level was considered 0. 95.
Result
All of three drugs were effective in treatment of spotting but base on qui-square test naproxen is the most effective one (p<0. 0001).
Conclusion
The findings of this study show that naproxen is more effective than indomethacin and ibuprofen in treatment of spotting due to IUD insertion. Therefore we suggest 5 days protocol of naproxen for curing spotting due to IUD insertion.
Language:
Persian
Published:
Iranina Journal of Obstetrics Gynecology and Infertility, Volume:17 Issue: 110, 2014
Pages:
8 to 15
magiran.com/p1310682  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!